Results 171 to 180 of about 170,339 (207)

Awareness and real-world practices in chronic lymphocytic leukemia: insights from a nationwide survey of Korean hematologists. [PDF]

Blood Res
Cha S, Kim SJ, Yoo KH, Park E, Byun JM.
europepmc   +1 more source

Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience. [PDF]

Front Oncol
D'Antiga M, Serafin A, Angotzi F, Cellini A, Bevilacqua A, Leone G, Danesin N, Cavarretta CA, Piazza F, Piovan E, Bonaldi L, Trentin L, Visentin A.   +12 more
europepmc   +1 more source

From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation. [PDF]

Curr Oncol
Castonguay M, Gagnon MF, Le Nguyen A, Terra R, Pilon SJ, Lépine G, LeBlanc R, Roy J, Cohen S, Fleury I, Mollica L, Veilleux O, Claveau JS.   +12 more
europepmc   +1 more source

Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations. [PDF]

Hemasphere
Charalampopoulou S, Ramos-Campoy S, Duran-Ferrer M, Puiggros A, Kamaso J, Nguyen-Khac F, Rigolin GM, Cuneo A, Collado R, García-Serra R, Haferlach C, Ortega M, Abrisqueta P, Bosch F, Zenz T, Blanco ML, Salgado R, García-Malo MD, Gimeno E, Lopez-Guillermo A, Campo E, Etter L, Schoumans J, Espinet B, Martin-Subero JI.   +24 more
europepmc   +1 more source

Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]

, 1984
Hiller, E., Jochum, Marianne
core  

Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia. [PDF]

Signal Transduct Target Ther
Böttcher M, Reemts L, Hengeveld PJ, Böttcher-Loschinski R, Bhuria V, Lu J, Materna-Reichelt S, Das D, Stojanović Gužvić N, Bruns H, Huber W, Zenz T, Schanze D, Zenker M, Dietrich S, Langerak AW, Mougiakakos D.   +16 more
europepmc   +1 more source

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. [PDF]

J Clin Med
Candan O, Tatli I, Bakisli A, Kula B, Korkut E, Yildirim ME, Gurbuz MA, Yilmaz AF, Atagunduz I, Tuglular AT, Toptas T.   +10 more
europepmc   +1 more source

Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia. [PDF]

Future Oncol
Shadman M, Chanan-Khan A, Campbell D, Xue M, Massoudi M, Williams R, Yang K, Tam CS.   +7 more
europepmc   +1 more source

Nanomechanical and Thermodynamic Alterations of Red Blood Cells in Chronic Lymphocytic Leukemia: Implications for Disease and Treatment Monitoring. [PDF]

Int J Mol Sci
Strijkova V, Katrova V, Ivanova M, Langari A, Gartcheva L, Guenova M, Alexandrova-Watanabe A, Taneva SG, Krumova S, Todinova S.   +9 more
europepmc   +1 more source